Development in attention functions and social processing: evidence from the Attention Network Test

According to the attention network approach, attention is best understood in terms of three functionally and neuroanatomically distinct networks – alerting, orienting, and executive attention. Recent findings showed that social information influences the efficiency of these networks in adults. Using some social and non-social variants of the Attentional Network Test (ANT), this study was aimed to evaluate the development of the three attention networks in childhood, also assessing the development of the ability to manage social or non-social conflicting information. Sixty-six children (three groups of 6, 8,and10 yearsofage)performedthreevariantsoftheoriginalANT,usingfish,schematic, or real faces looking to the left or right as target and flanker stimuli. Results showed an improvementfrom6to8and10 yearsofageinreactiontime(RT)andaccuracy,together with an improvement of executive control and a decrement in alerting. These developmental changes were not unique to social stimuli, and no differences were observed between social and no-social variants of the ANT. However, independently from the age of the children, a real face positively affected the executive control (as indexed by RTs) as compared to both a schematic face and a fish. Findings of this study suggest that attentional networks are still developing from 6 to 10 years of age and underline the importance of face information in modulating the efficiency of executive control

Impaired Sleep Quality in COPD Is Associated With Exacerbations The CanCOLD Cohort Study

BackgroundCOPD increases susceptibility to sleep disturbances, which may in turn predispose to increased respiratory symptoms. The objective of this study was to evaluate, in a population-based sample, the relationship between subjective sleep quality and risk of COPD exacerbations.MethodsData were obtained from the Canadian Cohort Obstructive Lung Disease (CanCOLD) study. Participants with COPD who had completed 18 months of follow-up were included. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI) and a three-factor analysis. Symptom-based (dyspnea or sputum change ≥ 48 h) and event-based (symptoms plus medication or unscheduled health services use) exacerbations were assessed. Association of PSQI with exacerbation rate was assessed by using negative binomial regression. Exacerbation-free survival was also assessed.ResultsA total of 480 participants with COPD were studied, including 185 with one or more exacerbations during follow-up and 203 with poor baseline sleep quality (PSQI score > 5). Participants with subsequent symptom-based exacerbations had higher median baseline PSQI scores than those without (6.0 [interquartile range, 3.0-8.0] vs 5.0 [interquartile range, 2.0-7.0]; P = .01), and they were more likely to have baseline PSQI scores > 5 (50.3% vs 37.3%; P = .01). Higher PSQI scores were associated with increased symptom-based exacerbation risk (adjusted rate ratio, 1.09; 95% CI, 1.01-1.18; P = .02) and event-based exacerbation risk (adjusted rate ratio, 1.10; 95% CI, 1.00-1.21; P = .048). The association occurred mainly in those with undiagnosed COPD. Strongest associations were with Factor 3 (sleep disturbances and daytime dysfunction). Time to symptom-based exacerbation was shorter in participants with poor sleep quality (adjusted hazard ratio, 1.49; 95% CI, 1.09-2.03).ConclusionsHigher baseline PSQI scores were associated with increased risk of COPD exacerbation over 18 months' prospective follow-up